Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

755P - A machine learning approach applied to gynaecological ultrasound to predict progression-free survival in ovarian cancer patients

Date

16 Sep 2021

Session

ePoster Display

Topics

Tumour Site

Ovarian Cancer

Presenters

Francesca Arezzo

Citation

Annals of Oncology (2021) 32 (suppl_5): S725-S772. 10.1016/annonc/annonc703

Authors

F. Arezzo1, V. Loizzi2, G. Cazzato3, V. Venerito4, E. Cicinelli2, G. Cormio2, C.M. Santarsiero2

Author affiliations

  • 1 Department Of Obstetrics And Gynecology, Policlinico Of Bari, 70124 - Bari/IT
  • 2 Department Of Obstetrics And Gynecology, Policlinico Of Bari, Bari/IT
  • 3 Pathology Unit, Policlinico Of Bari, Bari/IT
  • 4 Rheumatology Unit, Policlinico Of Bari, Bari/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 755P

Background

Ultrasound (US) is a cheap, non-invasive and well-recognized image modality for diagnosing and assessing ovarian cancer (OC). However, approximately 18% to 31% of adnexal lesions detected on US remain indeterminate. Machine learning (ML) is a promising tool for the implementation of complex multi-parametric algorithms. Despite the standardization of features capable of supporting the discrimination of ovarian masses into benign and malignant, there is the lack of accurate predictive modeling based on US examination for progression-free survival (PFS).

Methods

In this retrospective observational study, we analyzed patients with epithelial ovarian cancer(EOC) who were followed in a tertiary center from 2018 to 2019. Demographic, clinical and laboratory characteristics were collected as well as information about post-surgery histopathology. Furthermore, we recorded data about US examinations according to International Ovarian Tumor Analysis (IOTA) classification. Proper feature selection was used to determine an attribute core set. Random Forest (RFF) algorithm was trained and validated with 10-fold cross-validation to predict 12-month PFS. The accuracy of the algorithm was than assessed scoring accuracy and Area Under Receiver Operating Characteristic (AUROC).

Results

Our analysis included n.32OC patients with mean age of 54.1±14.9 years at diagnosis. Histotypes were n.19/32 (59.4%) serous carcinoma, n.5/32 (15.6%) mucinous, n.5/32 (15.6%) endometriod and n.3/32 (9.4%) clear cell. All patients underwent radical surgery. RFF showed an accuracy of 0.81, AUROC 0.91.

Conclusions

We developed an accurate model to predict 12-month PFS in patients with OC based on a ML algorithm applied to gynecological ultrasound evaluation, requiring few easy-to-collect attributes.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.